For clinical vendors
Your clinical program is enterprise-ready.We make the drug side ready too.
You do the clinical management. ApalyRx lowers the drug cost: every script assessed and routed in real time to its lowest net cost, on benefit, through the PBM or outside it.
A lower per-unit cost, still inside the benefit, defensible to an enterprise buyer. You manage the patient. We manage the prescription.
What enterprise buyers require
For sophisticated employers, on benefitis a must-have, not a nice-to-have.
Your program earns its place in the final round on clinical merit. What a large employer's fiduciary, CFO, CHRO, legal team, benefits consultant, and stop-loss carrier will not approve is an off-benefit discount card or direct-to-consumer drug program sitting next to it.
On-benefit operation is what makes the combined offer defensible to every one of them.
Pair with ApalyRx and the drug side meets the same standard your clinical program does.
How we work together
You manage the patient.We manage the prescription.
You own the clinical relationship, the patient, and your own employer contract. When you work with ApalyRx, the drug side shifts to us: eligibility, cost share, lowest net-cost fulfillment, on-benefit settlement, and reporting back to you and the employer. Your prescribers send the eRx to ApalyRx through standard e-prescribing, with no workflow change.
- The clinical relationship
- The patient
- The sale and your employer contract
- Eligibility
- Cost share
- Lowest net-cost fulfillment
- On-benefit settlement
- Reporting back to you and the employer
On benefit, by design
The compliancethat wins the enterprise deal.
- On benefit and reported through the employer's TPA or PBM
- Member cost share posts automatically to the deductible and MOOP, decisive for HDHPs
- HDHP and HSA IRS compliant
- Manufacturer-terms compliant
- Works alongside the existing PBM, routing to it when its price wins
The options
On benefit, or off.Only one clears enterprise scrutiny.
When the employer's team asks why this and not a card or the status quo, here is the answer on one page.
| Traditional PBM | Employer-funded card | ApalyRx on benefit | |
|---|---|---|---|
| Manufacturer-direct pricing | No | Yes | Yes |
| Operates on benefit | Yes | No | Yes |
| Counts toward deductible and MOOP | Yes | No | Yes |
| Preserves HSA eligibility for HDHP members | Yes | No | Yes |
| Compliant with manufacturer terms | Yes | No | Yes |
| Not taxable to member or employer | Yes | No | Yes |
| Fiduciary-defensible records | Partial | No | Yes |
An employer-funded card routed to a manufacturer cash-pay site is not a pharmacy benefit.
It is a taxable stipend with manufacturer compliance exposure attached.
No downside
Every script routedto its lowest-cost channel.
Every prescription is routed in real time to the lowest-cost fulfillment channel, including the member's local pharmacy and the employer's existing PBM pathway, so the employer never pays more. The combined offer lowers cost and stays defensible, which is what wins the enterprise deal.
The proof
Clinical vendors are already liveon the platform.
This is not theoretical. Clinical vendors run their drug programs on the ApalyRx rail today, on benefit, at enterprise employers.
Get started
Win the enterprise dealsyou are built for.
You stay clinical. We make the drug program defensible.
Together you close the employer neither could win alone.